{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T06:25:49Z","timestamp":1773987949117,"version":"3.50.1"},"reference-count":52,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.clinthera.2018.07.003","type":"journal-article","created":{"date-parts":[[2018,8,6]],"date-time":"2018-08-06T18:38:16Z","timestamp":1533580696000},"page":"1246-1254","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Live Attenuated Influenza Vaccine: Is Past Performance a Guarantee of Future Results?"],"prefix":"10.1016","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9921-0419","authenticated-orcid":false,"given":"Ravi","family":"Jhaveri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2018.07.003_bib0001","series-title":"Fields\u2019 Virology","first-page":"1152","article-title":"Orthomyxoviridae","author":"Shaw","year":"2013"},{"key":"10.1016\/j.clinthera.2018.07.003_bib0002","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/213612a0","article-title":"Adaptation and growth characteristics of influenza virus at 25 degrees C","volume":"213","author":"Maassab","year":"1967","journal-title":"Nature"},{"key":"10.1016\/j.clinthera.2018.07.003_bib0003","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/infdis\/165.4.727","article-title":"Immunization of infants and young children with live attenuated trivalent cold-recombinant influenza A H1N1, H3N2, and B vaccine","volume":"165","author":"Belshe","year":"1992","journal-title":"J Infect Dis"},{"key":"10.1016\/j.clinthera.2018.07.003_bib0004","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/infdis\/136.1.17","article-title":"Pilot studies on recombinant cold-adapted live type A and B influenza virus vaccines","volume":"136","author":"Davenport","year":"1977","journal-title":"J Infect Dis"},{"key":"10.1016\/j.clinthera.2018.07.003_bib0005","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/infdis\/146.1.71","article-title":"Cold-adapted recombinant influenza A virus vaccines in seronegative young children","volume":"146","author":"Wright","year":"1982","journal-title":"J Infect Dis"},{"key":"10.1016\/j.clinthera.2018.07.003_bib0006","first-page":"123","article-title":"Flumist, influenza vaccine live intranasal","volume":"3","year":"2002","journal-title":"Drugs R D"},{"key":"10.1016\/j.clinthera.2018.07.003_bib0007","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1056\/NEJM199805143382002","article-title":"The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children","volume":"338","author":"Belshe","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2018.07.003_bib0008","unstructured":"Chea T. MedImmune to Acquire Aviron. Available at: https:\/\/www.washingtonpost.com\/archive\/business\/2001\/12\/04\/medimmune-to-acquire-aviron\/6a301f98\u20132012ec-42c0-85ca-85ef8d5e0acf\/?utm_term=.00762dcab2fd. Accessed 26 March 2018."},{"key":"10.1016\/j.clinthera.2018.07.003_bib0009","unstructured":"US Food and Drug Administration. FluMist (Trivalent Influenza Vaccine Live, Intranasal): Supporting Documents Older than Three Years. Available at: http:\/\/wayback.archive-it.org\/7993\/20170722071650\/https:\/\/www.fda.gov\/BiologicsBloodVaccines\/Vaccines\/ApprovedProducts\/ucm094047.htm. Accessed 27 March 2018."},{"key":"10.1016\/j.clinthera.2018.07.003_bib0010","series-title":"AstraZeneca Buys MedImmune for $15.6 Billion","author":"Pollack","year":"2007"},{"key":"10.1016\/j.clinthera.2018.07.003_bib0011","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1097\/01.inf.0000237797.14283.cf","article-title":"Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma","volume":"25","author":"Fleming","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.clinthera.2018.07.003_bib0012","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1097\/01.inf.0000237829.66310.85","article-title":"Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections","volume":"25","author":"Ashkenazi","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.clinthera.2018.07.003_bib0013","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJMoa065368","article-title":"Live attenuated versus inactivated influenza vaccine in infants and young children","volume":"356","author":"Belshe","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2018.07.003_bib0014","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1056\/NEJMoa0808652","article-title":"Comparative efficacy of inactivated and live attenuated influenza vaccines","volume":"361","author":"Monto","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2018.07.003_bib0015","unstructured":"National Advisory Committee on Immunization. Statement on Seasonal Influenza Vaccine for 2013\u20132014. Available at: https:\/\/www.canada.ca\/content\/dam\/phac-aspc\/migration\/phac-aspc\/publicat\/ccdr-rmtc\/13vol39\/acs-dcc-4\/assets\/pdf\/13vol39-acs-dcc4-eng.pdf. Accessed 27 March 2018."},{"key":"10.1016\/j.clinthera.2018.07.003_bib0016","unstructured":"National Advisory Committee on Immunization. Revised Wording to the National Advisory Committee on Immunization (NACI) Recommendation for Live Attenuated Influenza Vaccine (LAIV) in Healthy Children and Adolescents 2\u20132017 Years of Age. Available at: https:\/\/www.canada.ca\/en\/public-health\/services\/reports-publications\/canada-communicable-disease-report-ccdr\/monthly-issue\/2013-39\/statement-on-seasonal-influenza-vaccine-2013-2014\/revised-wording-national-advisory-committee-on-immunization-naci-recommendation-live-attenuated-influenza-vaccine-laiv-healthy-children-adolescents-2.html. Accessed 27 March 2018."},{"key":"10.1016\/j.clinthera.2018.07.003_bib0017","year":"2011","journal-title":"Recommendations on the Use of Live, Attenuated Influenza Vaccine (FluMist): Supplemental Statement on Seasonal Influenza Vaccine for 2011-2012. Ottawa: Public Health Agency of Canada,"},{"key":"10.1016\/j.clinthera.2018.07.003_bib0018","unstructured":"Joint Committee on Vaccination and Immunisation. JCVI Statement on the Annual Influenza Vaccination Programme\u2014Extension of the Programme to Children. Available at: https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/224775\/JCVI-statement-on-the-annual-influenza-vaccination-programme-25-July-2012.pdf. Accessed 27 March 2018."},{"key":"10.1016\/j.clinthera.2018.07.003_bib0019","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1007\/s00103-013-1844-9","article-title":"Background paper to the recommendation for the preferential use of live-attenuated influenza vaccine in children aged 2-6 years in Germany","volume":"56","author":"Falkenhorst","year":"2013","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"10.1016\/j.clinthera.2018.07.003_bib0020","first-page":"691","article-title":"Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP)\u2014United States, 2014-15 influenza season","volume":"63","author":"Grohskopf","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.clinthera.2018.07.003_bib0021","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2016.21.45.30394","article-title":"Letter to the editor: Potential causes of the decreased effectiveness of the influenza A(H1N1)pdm09 strain in live attenuated influenza vaccines","volume":"21","author":"Ambrose","year":"2016","journal-title":"Euro Surveill"},{"key":"10.1016\/j.clinthera.2018.07.003_bib0022","unstructured":"Advisory Committee for Immunization Practices. Influenza Vaccine Effectiveness, 2016-17, US Flu VE Network & US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN). Available at: https:\/\/www.cdc.gov\/vaccines\/acip\/meetings\/downloads\/slides-2017-06\/flu-03-ferdinands.pdf. Accessed 12 April 2018."},{"key":"10.1016\/j.clinthera.2018.07.003_bib0023","unstructured":"Advisory Committee for Immunization Practices. Update on Effectiveness of Live-Attenuated Versus Inactivated Influenza Vaccines in Children and Adolescents Aged 2-18 Years-US Flu VE Network. Available at: http:\/\/www.cdc.gov\/vaccines\/acip\/meetings\/downloads\/slides-2014-10\/flu-03-flannery.pdf. Accessed 01 April 2018."},{"key":"10.1016\/j.clinthera.2018.07.003_bib0024","unstructured":"Centers for Disease Control and Prevention. CDC Statement on LAIV Effectiveness and Vaccination of Children. Available at: https:\/\/www.cdc.gov\/flu\/news\/nasal-spray-effectiveness.htm. Accessed 30 March 2018."},{"key":"10.1016\/j.clinthera.2018.07.003_bib0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003831","article-title":"A single amino acid in the stalk region of the H1N1pdm influenza virus HA protein affects viral fusion, stability and infectivity","volume":"10","author":"Cotter","year":"2014","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.clinthera.2018.07.003_bib0026","doi-asserted-by":"crossref","first-page":"4910","DOI":"10.1016\/j.vaccine.2015.07.044","article-title":"Randomized evaluation of live attenuated vs. inactivated influenza vaccines in schools (RELATIVES) cluster randomized trial: Pilot results from a household surveillance study to assess direct and indirect protection from influenza vaccination","volume":"33","author":"Kwong","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.clinthera.2018.07.003_bib0027","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.vaccine.2015.11.010","article-title":"Effectiveness of live attenuated influenza vaccine and inactivated influenza vaccine in children 2-17 years of age in 2013-2014 in the United States","volume":"34","author":"Caspard","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.clinthera.2018.07.003_bib0028","first-page":"10","article-title":"Early estimates of seasonal influenza vaccine effectiveness\u2014United States, January 2015","volume":"64","author":"Flannery","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.clinthera.2018.07.003_bib0029","doi-asserted-by":"crossref","first-page":"818","DOI":"10.15585\/mmwr.mm6430a3","article-title":"Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices, United States, 2015-16 influenza season","volume":"64","author":"Grohskopf","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.clinthera.2018.07.003_bib0030","doi-asserted-by":"crossref","first-page":"567","DOI":"10.15585\/mmwr.mm6522a3","article-title":"Influenza Activity\u2014United States, 2015-16 season and composition of the 2016-17 influenza vaccine","volume":"65","author":"Davlin","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.clinthera.2018.07.003_bib0031","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6505a1","article-title":"Prevention and control of seasonal influenza with vaccines","volume":"65","author":"Grohskopf","year":"2016","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.clinthera.2018.07.003_bib0032","unstructured":"Advisory Committee for Immunization Practices. Advisory Committee on Immunization Practices: Summary Report June 22-23, 2016, Atlanta, Georgia. Available at: https:\/\/www.cdc.gov\/vaccines\/acip\/meetings\/downloads\/min-archive\/min-2016-06.pdf. Accessed 30 March 2018."},{"key":"10.1016\/j.clinthera.2018.07.003_bib0033","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2016.21.38.30346","article-title":"Effectiveness of the live attenuated and the inactivated influenza vaccine in two-year-olds\u2014a nationwide cohort study Finland, influenza season 2015\/16","volume":"21","author":"Nohynek","year":"2016","journal-title":"Euro Surveill"},{"key":"10.1016\/j.clinthera.2018.07.003_bib0034","article-title":"Effectiveness of seasonal influenza vaccine for adults and children in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015\/16 end-of-season results","volume":"21","author":"Pebody","year":"2016","journal-title":"Euro Surveill"},{"key":"10.1016\/j.clinthera.2018.07.003_bib0035","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2017.22.4.30450","article-title":"Live attenuated influenza vaccine effectiveness against hospitalisation due to laboratory-confirmed influenza in children two to six years of age in England in the 2015\/16 season","volume":"22","author":"Pebody","year":"2017","journal-title":"Euro Surveill"},{"key":"10.1016\/j.clinthera.2018.07.003_bib0036","unstructured":"National Immunization Technical Advisory Group Resource Center. ACIP Recommends Not to Use LAIV During 2016-17 Flu Season. Available at: http:\/\/www.nitag-resource.org\/news-and-events\/news\/84-acip-recommends-not-to-use-laiv-during-2016-17-flu-season. Accessed 27 June 2018."},{"key":"10.1016\/j.clinthera.2018.07.003_bib0037","series-title":"Intranasal FluMISSED its target","author":"Bernstein","year":"2016"},{"key":"10.1016\/j.clinthera.2018.07.003_bib0038","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.clinthera.2016.11.018","article-title":"A feasibility trial of home administration of intranasal vaccine by parents to eligible children","volume":"39","author":"Jhaveri","year":"2017","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2018.07.003_bib0039","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.2353\/ajpath.2007.070248","article-title":"Human and avian influenza viruses target different cells in the lower respiratory tract of humans and other mammals","volume":"171","author":"van Riel","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1016\/j.clinthera.2018.07.003_bib0040","unstructured":"Centers for Disease Control and Prevention. 2017-2018 Influenza Season Week 13 ending March 31, 2018 Available at: https:\/\/www.cdc.gov\/flu\/weekly\/index.htm. Accessed 11 April 2018."},{"key":"10.1016\/j.clinthera.2018.07.003_bib0041","unstructured":"Centers for Disease Control and Prevention. Interim Estimates of 2017\u201318 Seasonal Influenza Vaccine Effectiveness against Medically Attended Influenza from the US Flu VE Network. Available at: https:\/\/www.cdc.gov\/vaccines\/acip\/meetings\/downloads\/slides-2018-02\/flu-04-Flannery-508.pdf. Accessed 10 April 2018."},{"key":"10.1016\/j.clinthera.2018.07.003_bib0042","unstructured":"Centers for Disease Control and Prevention. Flu Vaccination Coverage, United States, 2016-17 Influenza Season. Available at: https:\/\/www.cdc.gov\/flu\/fluvaxview\/coverage-1617estimates.htm. Accessed 10 April 2018."},{"key":"10.1016\/j.clinthera.2018.07.003_bib0043","doi-asserted-by":"crossref","first-page":"5278","DOI":"10.1016\/j.vaccine.2017.07.067","article-title":"Influenza vaccination rates in children decline when the live attenuated influenza vaccine is not recommended","volume":"35","author":"Fogel","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.clinthera.2018.07.003_bib0044","first-page":"997","article-title":"Estimated influenza illnesses and hospitalizations averted by influenza vaccination\u2014United States, 2012-13 influenza season","volume":"62","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.clinthera.2018.07.003_bib0045","doi-asserted-by":"crossref","first-page":"e66312","DOI":"10.1371\/journal.pone.0066312","article-title":"Influenza illness and hospitalizations averted by influenza vaccination in the United States, 2005-2011","volume":"8","author":"Kostova","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.clinthera.2018.07.003_bib0046","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/pch\/pxx195","article-title":"Intranasal influenza vaccine: Why does Canada have different recommendations from the USA on its use?","volume":"23","author":"Tam","year":"2018","journal-title":"Paediatr Child Health"},{"key":"10.1016\/j.clinthera.2018.07.003_bib0047","unstructured":"European Scientific Working Group on Influenza. Universal Vaccination of Children the Finnish Approach. Available at: http:\/\/eswi.org\/ippc\/wp-content\/uploads\/sites\/14\/2017\/06\/8-Nohynek.pdf. Accessed 11 April 2018."},{"key":"10.1016\/j.clinthera.2018.07.003_bib0048","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2017.22.44.17-00306","article-title":"End-of-season influenza vaccine effectiveness in adults and children, United Kingdom, 2016\/17","volume":"22","author":"Pebody","year":"2017","journal-title":"Euro Surveill"},{"key":"10.1016\/j.clinthera.2018.07.003_bib0049","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.vaccine.2017.12.003","article-title":"Impact of live attenuated influenza vaccination programme for healthy children in Northern Ireland: a comparison of seven influenza seasons, 2010\/11-2016\/17","volume":"36","author":"Gallagher","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.clinthera.2018.07.003_bib0050","unstructured":"Centers for Disease Control and Prevention. Results of Randomized Trial of a New H1N1 LAIV Strain in US Children. Available at: https:\/\/www.cdc.gov\/vaccines\/acip\/meetings\/downloads\/slides-2018-02\/flu-05-Mallory-508.pdf. Accessed 10 April 2018."},{"key":"10.1016\/j.clinthera.2018.07.003_bib0051","unstructured":"Centers for Disease Control and Prevention. Review of Effectiveness of Live Attenuated Influenza Vaccine. Available at: https:\/\/www.cdc.gov\/vaccines\/acip\/meetings\/downloads\/slides-2018-02\/flu-06-Grohskopf-508.pdf. Accessed 11 April 2018."},{"key":"10.1016\/j.clinthera.2018.07.003_bib0054","unstructured":"World Health Organization. Southern Hemisphere. Available at: http:\/\/apps.who.int\/flumart\/Default?ReportNo=5&Hemisphere=Southern. Accessed 12 April 2018."}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291818302741?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291818302741?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T10:53:13Z","timestamp":1537786393000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291818302741"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":52,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S0149291818302741"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2018.07.003","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Live Attenuated Influenza Vaccine: Is Past Performance a Guarantee of Future Results?","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2018.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}